TRELLIS-8 PERIPHERAL INFUSION SYSTEM— 510(k) K130904

Substantially Equivalent

Covidien

FDA 510(k) clearance K130904 for TRELLIS-8 PERIPHERAL INFUSION SYSTEM, Substantially Equivalent on 2013-10-25. Applicant: Covidien.

Clearance details

Applicant: Covidien
Product code: Code QEY
Advisory panel: Cardiovascular
Date received: 2013-04-01
Decision date: 2013-10-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mansfield, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.